Macrophages

Jan 08, 2020

Therapeutic Solutions International Reports Inhibition of Microglial Activation with NeuroStilbene

Nov 17, 2019

3SBio Selects Verseau's PSGL-1-targeted Antibody VTX-0811 as First Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration

Nov 16, 2019

Carisma Therapeutics Announces Investor Conference Participation

Nov 04, 2019

Dracen Pharmaceuticals announces DRP-104 presentations at the 2019 Society of Immunotherapy of Cancer (SITC) Meeting

Sep 09, 2019

Phio Pharmaceuticals Announces Research Collaboration with Carisma Therapeutics to Evaluate its Self-Delivering RNAi Technology to Enhance Macrophage-Based Adoptive Cell Therapy

Sep 03, 2019

Macrophage Pharma Appoints Dr Søren Bregenholt as Chief Executive Officer

Aug 27, 2019

PIONYR Immunotherapeutics Announces Key Leadership Team Addition and Clinical Candidates Targeting Tumor-Associated Macrophages

Jun 27, 2018

Carisma Therapeutics Announces a $53 Million Series A Financing to Develop Novel CAR Macrophage Cellular Immunotherapy

May 24, 2018

Old bones can heal with proper signals: Targeting macrophages to stimulate osteoblasts

Mar 27, 2018

BioIVT Acquires Ascendance Biotechnology, Expanding its Drug Safety Testing and Toxicology Portfolios

Aug 23, 2017

Macrophage Pharma Limited Extends Series A Round to Include New Investor Merck Ventures